Drug approved to treat osteoporosis shows promise in pre-clinical diabetes research
Thursday, June 18, 2015 - 14:00
in Health & Medicine
A drug commonly used to treat osteoporosis in humans also stimulates the production of cells that control insulin balance in diabetic mice, researchers have found. While other compounds have been shown to have this effect, the drug (Denosumab) is already FDA approved and could more quickly move to clinical trials as a diabetes treatment.